VIA
GPCR icon

Virtus Investment Advisers’s Structure Therapeutics GPCR Stock Holding History

Virtus Investment Advisers’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$409K Buy
7,622
+3,557
+88% +$157K 0.1% 265
2026
Q1 		$196K Buy
4,065
+98
+2% +$6.71K 0.05% 364
2025
Q4 		$276K Sell
3,967
-1,154
-23% -$47.1K 0.08% 277
2025
Q3 		$143K Buy
5,121
+889
+21% +$17.7K 0.04% 383
2025
Q2 		$87.8K Sell
4,232
-945
-18% -$20.8K 0.03% 393
2025
Q1 		$89.6K Buy
+5,177
New +$127K 0.02% 435

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Virtus Investment Advisers's GPCR Position: Q2 2026 in Review

Virtus Investment Advisers increased its Structure Therapeutics (GPCR) stake by 88% in Q2 2026, buying an estimated $157K and bringing the position to 7,622 shares worth $409K. The position accounts for 0.1% of the portfolio, ranked #265.

Virtus Investment Advisers first reported a position in GPCR in Q1 2025 and has held it in 6 quarters since. 191 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Virtus Investment Advisers held 7,622 shares of Structure Therapeutics worth $409K as of Q2 2026.
  • Virtus Investment Advisers bought 3,557 Structure Therapeutics shares in Q2 2026, an estimated $157K.
  • Structure Therapeutics made up 0.1% of Virtus Investment Advisers's portfolio in Q2 2026, its #265 holding.
  • Virtus Investment Advisers first reported a position in Structure Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 191 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.